Bain Capital-backed Heartflow eyes $1.3 billion valuation in US IPO
Aiming for a valuation of $1.32 billion indicates strong market interest. Previous IPOs in healthcare have often performed well due to demand for innovative solutions.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Aiming for a valuation of $1.32 billion indicates strong market interest. Previous IPOs in healthcare have often performed well due to demand for innovative solutions.
What happened, with direct paths to the underlying reporting
Heartflow aims for a $1.32 billion valuation in its IPO.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.